Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy

David M. Asmuth, Zhong Min Ma, Anthony Albanese, Netanya G. Sandler, Sridevi Devaraj, Thomas H. Knight, Neil M. Flynn, Tammy Yotter, Juan Carlos Garcia, Emily Tsuchida, Tsung Teh Wu, Daniel C. Douek, Christopher J. Miller

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Objectives: To examine the impact of serum-derived bovine immunoglobulin, an oral medical food known to neutralize bacterial antigen and reduce intestinal inflammation, on restoration of mucosal immunity and gastrointestinal function in individuals with HIV enteropathy. Design: Open-label trial with intensive 8-week phase of bovine serum immunoglobulin (SBI) 2.5 g twice daily with a 4-week washout period and an optional 9-month extension study. Methods: HIV enteropathy was defined as chronic gastrointestinal symptoms including frequent loose or watery stools despite no identifiable, reversible cause. Upper endoscopy for tissue immunofluorescent antibody assay and disaccharide gut permeability/absorption studies were performed before and after 8 weeks of SBI to test mucosal immunity and gastrointestinal function. Blood was collected for markers of microbial translocation, inflammation, and collagen kinetics. A validated gastrointestinal questionnaire assessed changes in symptoms. Results: All eight participants experienced profound improvement in symptoms with reduced bowel movements/day (P=0.008) and improvements in stool consistency (P=0.008). Gut permeability was normal before and after the intervention, but D-xylose absorption increased in seven of eight participants. Mucosal CD4+ lymphocyte densities increased by a median of 139.5 cells/mm2 from 213 to 322 cells/mm2 (P=0.016). Intestinal-fatty acid binding protein (I-FABP), a marker of enterocyte damage, initially rose in seven of eight participants after 8 weeks (P=0.039), and then fell below baseline in four of five who continued receiving SBI (P=0.12). Baseline serum I-FABP levels were negatively correlated with subsequent rise in mucosal CD4+ lymphocyte densities (r= -0.74, P=0.046). Conclusion: SBI significantly increases intestinal mucosal CD4+ lymphocyte counts, improves duodenal function, and showed evidence of promoting intestinal repair in the setting of HIV enteropathy.

Original languageEnglish (US)
Pages (from-to)2207-2217
Number of pages11
JournalAIDS
Volume27
Issue number14
DOIs
StatePublished - Sep 10 2013
Externally publishedYes

Fingerprint

HIV Enteropathy
Immunoglobulins
Fatty Acid-Binding Proteins
Mucosal Immunity
Permeability
Serum
Lymphocytes
Inflammation
Bacterial Antigens
Enterocytes
Disaccharides
Xylose
CD4 Lymphocyte Count
Endoscopy
Blood Proteins
Collagen
Food
Antibodies

Keywords

  • Bovine immunoglobulin
  • D-xylose absorption
  • Gastrointestinal associated lymphoid tissue
  • Gut permeability
  • HIV enteropathy
  • Immune reconstitution
  • Immunohistochemistry
  • Intestinal fatty acid binding protein
  • Monocyte chemotaxis protein-1

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Cite this

Asmuth, D. M., Ma, Z. M., Albanese, A., Sandler, N. G., Devaraj, S., Knight, T. H., ... Miller, C. J. (2013). Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy. AIDS, 27(14), 2207-2217. https://doi.org/10.1097/QAD.0b013e328362e54c

Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy. / Asmuth, David M.; Ma, Zhong Min; Albanese, Anthony; Sandler, Netanya G.; Devaraj, Sridevi; Knight, Thomas H.; Flynn, Neil M.; Yotter, Tammy; Garcia, Juan Carlos; Tsuchida, Emily; Wu, Tsung Teh; Douek, Daniel C.; Miller, Christopher J.

In: AIDS, Vol. 27, No. 14, 10.09.2013, p. 2207-2217.

Research output: Contribution to journalArticle

Asmuth, DM, Ma, ZM, Albanese, A, Sandler, NG, Devaraj, S, Knight, TH, Flynn, NM, Yotter, T, Garcia, JC, Tsuchida, E, Wu, TT, Douek, DC & Miller, CJ 2013, 'Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy', AIDS, vol. 27, no. 14, pp. 2207-2217. https://doi.org/10.1097/QAD.0b013e328362e54c
Asmuth, David M. ; Ma, Zhong Min ; Albanese, Anthony ; Sandler, Netanya G. ; Devaraj, Sridevi ; Knight, Thomas H. ; Flynn, Neil M. ; Yotter, Tammy ; Garcia, Juan Carlos ; Tsuchida, Emily ; Wu, Tsung Teh ; Douek, Daniel C. ; Miller, Christopher J. / Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy. In: AIDS. 2013 ; Vol. 27, No. 14. pp. 2207-2217.
@article{e062a8de2f5946dab633e701cf507332,
title = "Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy",
abstract = "Objectives: To examine the impact of serum-derived bovine immunoglobulin, an oral medical food known to neutralize bacterial antigen and reduce intestinal inflammation, on restoration of mucosal immunity and gastrointestinal function in individuals with HIV enteropathy. Design: Open-label trial with intensive 8-week phase of bovine serum immunoglobulin (SBI) 2.5 g twice daily with a 4-week washout period and an optional 9-month extension study. Methods: HIV enteropathy was defined as chronic gastrointestinal symptoms including frequent loose or watery stools despite no identifiable, reversible cause. Upper endoscopy for tissue immunofluorescent antibody assay and disaccharide gut permeability/absorption studies were performed before and after 8 weeks of SBI to test mucosal immunity and gastrointestinal function. Blood was collected for markers of microbial translocation, inflammation, and collagen kinetics. A validated gastrointestinal questionnaire assessed changes in symptoms. Results: All eight participants experienced profound improvement in symptoms with reduced bowel movements/day (P=0.008) and improvements in stool consistency (P=0.008). Gut permeability was normal before and after the intervention, but D-xylose absorption increased in seven of eight participants. Mucosal CD4+ lymphocyte densities increased by a median of 139.5 cells/mm2 from 213 to 322 cells/mm2 (P=0.016). Intestinal-fatty acid binding protein (I-FABP), a marker of enterocyte damage, initially rose in seven of eight participants after 8 weeks (P=0.039), and then fell below baseline in four of five who continued receiving SBI (P=0.12). Baseline serum I-FABP levels were negatively correlated with subsequent rise in mucosal CD4+ lymphocyte densities (r= -0.74, P=0.046). Conclusion: SBI significantly increases intestinal mucosal CD4+ lymphocyte counts, improves duodenal function, and showed evidence of promoting intestinal repair in the setting of HIV enteropathy.",
keywords = "Bovine immunoglobulin, D-xylose absorption, Gastrointestinal associated lymphoid tissue, Gut permeability, HIV enteropathy, Immune reconstitution, Immunohistochemistry, Intestinal fatty acid binding protein, Monocyte chemotaxis protein-1",
author = "Asmuth, {David M.} and Ma, {Zhong Min} and Anthony Albanese and Sandler, {Netanya G.} and Sridevi Devaraj and Knight, {Thomas H.} and Flynn, {Neil M.} and Tammy Yotter and Garcia, {Juan Carlos} and Emily Tsuchida and Wu, {Tsung Teh} and Douek, {Daniel C.} and Miller, {Christopher J.}",
year = "2013",
month = "9",
day = "10",
doi = "10.1097/QAD.0b013e328362e54c",
language = "English (US)",
volume = "27",
pages = "2207--2217",
journal = "AIDS",
issn = "0269-9370",
publisher = "Lippincott Williams and Wilkins",
number = "14",

}

TY - JOUR

T1 - Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy

AU - Asmuth, David M.

AU - Ma, Zhong Min

AU - Albanese, Anthony

AU - Sandler, Netanya G.

AU - Devaraj, Sridevi

AU - Knight, Thomas H.

AU - Flynn, Neil M.

AU - Yotter, Tammy

AU - Garcia, Juan Carlos

AU - Tsuchida, Emily

AU - Wu, Tsung Teh

AU - Douek, Daniel C.

AU - Miller, Christopher J.

PY - 2013/9/10

Y1 - 2013/9/10

N2 - Objectives: To examine the impact of serum-derived bovine immunoglobulin, an oral medical food known to neutralize bacterial antigen and reduce intestinal inflammation, on restoration of mucosal immunity and gastrointestinal function in individuals with HIV enteropathy. Design: Open-label trial with intensive 8-week phase of bovine serum immunoglobulin (SBI) 2.5 g twice daily with a 4-week washout period and an optional 9-month extension study. Methods: HIV enteropathy was defined as chronic gastrointestinal symptoms including frequent loose or watery stools despite no identifiable, reversible cause. Upper endoscopy for tissue immunofluorescent antibody assay and disaccharide gut permeability/absorption studies were performed before and after 8 weeks of SBI to test mucosal immunity and gastrointestinal function. Blood was collected for markers of microbial translocation, inflammation, and collagen kinetics. A validated gastrointestinal questionnaire assessed changes in symptoms. Results: All eight participants experienced profound improvement in symptoms with reduced bowel movements/day (P=0.008) and improvements in stool consistency (P=0.008). Gut permeability was normal before and after the intervention, but D-xylose absorption increased in seven of eight participants. Mucosal CD4+ lymphocyte densities increased by a median of 139.5 cells/mm2 from 213 to 322 cells/mm2 (P=0.016). Intestinal-fatty acid binding protein (I-FABP), a marker of enterocyte damage, initially rose in seven of eight participants after 8 weeks (P=0.039), and then fell below baseline in four of five who continued receiving SBI (P=0.12). Baseline serum I-FABP levels were negatively correlated with subsequent rise in mucosal CD4+ lymphocyte densities (r= -0.74, P=0.046). Conclusion: SBI significantly increases intestinal mucosal CD4+ lymphocyte counts, improves duodenal function, and showed evidence of promoting intestinal repair in the setting of HIV enteropathy.

AB - Objectives: To examine the impact of serum-derived bovine immunoglobulin, an oral medical food known to neutralize bacterial antigen and reduce intestinal inflammation, on restoration of mucosal immunity and gastrointestinal function in individuals with HIV enteropathy. Design: Open-label trial with intensive 8-week phase of bovine serum immunoglobulin (SBI) 2.5 g twice daily with a 4-week washout period and an optional 9-month extension study. Methods: HIV enteropathy was defined as chronic gastrointestinal symptoms including frequent loose or watery stools despite no identifiable, reversible cause. Upper endoscopy for tissue immunofluorescent antibody assay and disaccharide gut permeability/absorption studies were performed before and after 8 weeks of SBI to test mucosal immunity and gastrointestinal function. Blood was collected for markers of microbial translocation, inflammation, and collagen kinetics. A validated gastrointestinal questionnaire assessed changes in symptoms. Results: All eight participants experienced profound improvement in symptoms with reduced bowel movements/day (P=0.008) and improvements in stool consistency (P=0.008). Gut permeability was normal before and after the intervention, but D-xylose absorption increased in seven of eight participants. Mucosal CD4+ lymphocyte densities increased by a median of 139.5 cells/mm2 from 213 to 322 cells/mm2 (P=0.016). Intestinal-fatty acid binding protein (I-FABP), a marker of enterocyte damage, initially rose in seven of eight participants after 8 weeks (P=0.039), and then fell below baseline in four of five who continued receiving SBI (P=0.12). Baseline serum I-FABP levels were negatively correlated with subsequent rise in mucosal CD4+ lymphocyte densities (r= -0.74, P=0.046). Conclusion: SBI significantly increases intestinal mucosal CD4+ lymphocyte counts, improves duodenal function, and showed evidence of promoting intestinal repair in the setting of HIV enteropathy.

KW - Bovine immunoglobulin

KW - D-xylose absorption

KW - Gastrointestinal associated lymphoid tissue

KW - Gut permeability

KW - HIV enteropathy

KW - Immune reconstitution

KW - Immunohistochemistry

KW - Intestinal fatty acid binding protein

KW - Monocyte chemotaxis protein-1

UR - http://www.scopus.com/inward/record.url?scp=84884500301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884500301&partnerID=8YFLogxK

U2 - 10.1097/QAD.0b013e328362e54c

DO - 10.1097/QAD.0b013e328362e54c

M3 - Article

VL - 27

SP - 2207

EP - 2217

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 14

ER -